Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?


Ariad (ARIA) Shares Nosedive 75 Percent as FDA Partially Halts Leukemia Drug Trials

By  +Follow October 9, 2013 8:03AM
Tickers Mentioned:

Shares of Ariad Pharmaceuticals, Inc. (ARIA) are getting hammered in early Wednesday trading after discussions with the Food and Drug Administration have resulted in a hold on trial enrollment for its kinase inhibiting leukemia drug Iclusig (ponatinib) because of safety concerns.

Iclusig was approved last December as a treatment for resistant or intolerant chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia. The drug received accelerated approval for the indications based on phase 2 clinical data on only five years of clinical studies.

Follow up after 24 months of Iclusig therapy showed blood clots – called “serious arterial thrombosis” – occurred in 11.8 percent of patients. That’s up from the 8 percent of patients at 11-month follow-up evaluations. The increase in clots has spurred the FDA to allow current patients to continue with trials of Iclusig, but no new patients can be enrolled at this time until changes in dosing levels and modifications are enacted. Upon agreements with the FDA on these items, it is expected that enrollments will resume.

Researchers also observed that 6.2 percent of treated patients had cardiovascular events, 4.0 percent had cerebrovascular events and 3.6 percent had peripheral vascular events.  It was also noted that some patients had more than one type of event.

Reductions in dosing for current patients will be lowered from 45 mg daily to 30 mg daily unless a patient has achieved a major molecular response or reaches one in the future, in which case dosing will be dropped to daily level of 15 mg. Data from clinical trials has shown efficacy even after dose reduction.  Future consideration for enrollment will exclude patients who have experienced prior arterial thrombosis that has resulted in a heart attack or a stroke.

The FDA will be issuing a safety warning on Iclusig and Ariad will be changing its warnings on the box.

Ariad is currently running eight trials to evaluate Iclusig for a variety of tumors, including chronic myeloid leukemia, lung cancer, gastrointestinal stromal tumors, thyroid cancer, and Acute myeloid leukemia. The much-watched EPIC trial is comparing Iclusig to Novartis’ (NVS) Gleevec in chronic myeloid leukemia patients, which many analysts consider key to Iclusig reaching a greater patient population as an alternative for those who have grown resistant to current drugs.

Ariad entered Wednesday with a market capitalization over $3 billion, but the news has stripped the majority of the company’s value as toxicity concerns have investors questioning future sales. Shares closed on Tuesday at $17.14 and plunged as low as $4.00 (-76.7%) in today’s trading, before bouncing back up near $5.00 each to pare losses to around 70 percent as the lunch hour approaches.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.

Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for ARIA
Victor Roberts, MD
22 Oct 14 20:55:08
@grdollasign look at RGLS , with one small Phase 1 good data , it's up by 100% over night! Where will $ARIA be w/AP26113 & other pipelines?
Victor Roberts, MD
22 Oct 14 20:36:12
@grdollasign less institutional ownership looks like good thing for $ARIA ! Less shares available to loan to short. short covering started!
Victor Roberts, MD
22 Oct 14 20:16:06
@grdollasign he is still $ARIA CEO! there's no public disagreement w/him being CEO, Yet! 70% Institutional ownership, they're Ok so far!
Ross Anderson
22 Oct 14 20:14:57
@Drragu Agreed..visionary. Irrelevant when you never know the truth. $ARIA will flourish when @harveyberger steps down or is forced out.
Victor Roberts, MD
22 Oct 14 20:11:16
@grdollasign u have to aways hedge your investment in a growing company like $ARIA. It's pipeline and drug development platform is visionary
Victor Roberts, MD
22 Oct 14 18:23:52
$ARIA Still green on weekly chart! BB are pinching, big move coming soon! http://t.co/beCOFQQfSs
22 Oct 14 16:26:14
http://t.co/OnhjJ9dsFO Verified $22.27 profit in $ARIA none
Ross Anderson
22 Oct 14 15:03:38
@harveyberger are you outta there yet? I want to get back in $ARIA but cant because you are killing the company. You cannot be trusted.
22 Oct 14 14:43:27
$ARIA good news more like a downgrade for ariad
22 Oct 14 14:29:45
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/z2noBUWrEP $FASC $ARIA $TUCN
22 Oct 14 14:24:14
ARIA 5.59 Stock Charts $ARIA Ariad Pharmaceuticals Inc. (NASDAQ) Last Updated: 10/22/2014 16:24:11 ARIA Stock http://t.co/xSW3g65LtD
22 Oct 14 14:14:11
$ADHD falling $ARIA footsteps- $ARIA went from $24 to $5 and when everyone was looking for a bounce it went to $2.15 and than rebounded!
22 Oct 14 13:11:49
$ARIA Nasdaq stocks posting largest percentage increases http://t.co/3F6IwXoVBZ #BiotechTraderHandbook--> http://t.co/JDdc1OTfZF
Stock Relay
22 Oct 14 13:07:36
stockblaster14: Stock Alerts: Ariad Pharmaceuticals (ARIA) 5.61 $ARIA Insider http://t.co/IKQEiU5iYw
22 Oct 14 13:03:37
Ariad Pharmaceuticals (ARIA) 5.61 $ARIA Insider Trading Alerts for Micron, CSX, Ariad Pharmaceuticals, IBM, Si http://t.co/XtSCPzVNWj
22 Oct 14 12:13:41
@bradloncar is the $aria eu decision due sometime in oct?
Rosner Stocks
22 Oct 14 11:41:19
$BITA Bid Click Here: http://t.co/dLmVn27eTg Also See: $ARIA $TSLA $EZU $ARIA ~
Dan Forman
22 Oct 14 11:26:45
$aria moved too much in too short a period of time. Profit taking day. Considering adding to my position for the next leg up
22 Oct 14 10:38:38
$ARIA currently -1.55% #options #BiotechTraderHandbook--> http://t.co/JDdc1OTfZF
Rosner Stocks
22 Oct 14 10:34:59
$ARIA Shares Click Here: http://t.co/G24nFDPiMu Also See: $AMBA $MS $EXK $QLD ~
22 Oct 14 10:29:27
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/z2noBUWrEP $FASC $ARIA $TUCN
Investors Hangout
22 Oct 14 10:21:30
$ARIA Market Cap Click Here: http://t.co/kN8dDkjwah Also See: $VXX $SLB $WWAG $TIP ~
Investors Hangout
22 Oct 14 10:12:45
$ARIA Volume Click Here: http://t.co/EDH2DlqEgs Also See: $NKE $RSX $SLV $CLF ~
Chasing Stars
22 Oct 14 10:08:09
$ARIA Prev Close Click Here: http://t.co/Y4gvJesP4F Also See: $V $TSLA $ARWR $ARIA ~
22 Oct 14 10:03:50
ARIA Stock Chart $ARIA $BIIB $XLI $QASP http://t.co/zzoBhGZObZ http://t.co/kMVfVJHa1R
Rosner Stocks
22 Oct 14 09:55:55
$AMBA Financials Click Here: http://t.co/V1Cpv9BRx2 Also See: $BRK/B $CENX $ELTP $ARIA ~
Stock Forums
22 Oct 14 09:53:54
$ARIA Company Info Click Here: http://t.co/MX6PubpDZ2 Also See: $SLB $SLB $EWL $T ~
Rosner Stocks
22 Oct 14 09:44:05
$AKRX Stock Forum Click Here: http://t.co/7zRDJJXvZW Also See: $XLF $ARIA $AMBA $EEM ~
Stock Forums
22 Oct 14 09:19:53
$AMBA Market Cap Click Here: http://t.co/7Lp8c4YSdj Also See: $CREE $ARIA $WPCS $FNMA ~
22 Oct 14 09:12:12
$TWTR TA $TWTR Most recent stock chart and technical analysis. $XLV $SPLK $SDS $TSLA $ARIA $T http://stockchar http://t.co/Q8SxMB1BmU
22 Oct 14 09:01:43
$GPRO Chart $GPRO Most recent stock chart and technical analysis. $PLUG $BAC $ARIA $CAT $HIMX $FB http://stock http://t.co/7hr51DfPXw
22 Oct 14 08:53:48
RT @Drragu: Commented on StockTwits: What if $ARIA gets funding by Big Pharma Partnership? Epic Short Squeeze! Like in PBYI/K... http://t.c…
Investors Hangout
22 Oct 14 08:16:36
DennyT: ARIA Company Info $ARIA $HYG $ISH $QLD $AG Buy or http://t.co/keZwqYkthB
Investors Hangout
22 Oct 14 08:15:34
DennyT: ARIA Company Info $ARIA $HYG $ISH $QLD $AG Buy or http://t.co/OppgoN76si
22 Oct 14 07:56:10
ARIA Company Info $ARIA $HYG $ISH $QLD $AG Buy or Sell?,Volume,High,Company News,On Radar Stock Quote http://w http://t.co/bGLB1aKrMH
22 Oct 14 07:20:33
Sector updates $ARIA at +1.21% #options #BiotechTraderHandbook--> http://t.co/QvDIRU65Zv
22 Oct 14 07:01:52
$ARIA $AVNR $KERX all rallying!!! #news #breakingnews #cnbc $lake #DallasEbola $shpg $cmrx $tkmr $ibio $bcrx $SRPT $NLNK #ZMapp
T Abuhasna
22 Oct 14 06:25:46
$ARIA $S $VPOR $PSID something's a cookin.... $$$$
Chasing Stars
22 Oct 14 06:23:04
$XLB Prev Close Click Here: http://t.co/I29WGwkpAw Also See: $AKRX $NFLX $ARIA $ISNS ~
Rosner Stocks
22 Oct 14 04:42:48
$VXX 52Wk Low Click Here: http://t.co/LW2blow6hj Also See: $ARIA $WWAG $FNMA $YPF ~
Phil Martin
22 Oct 14 04:28:52
$ARIA http://t.co/ydH3WUkzH1
Stephen s
22 Oct 14 04:27:42
RT @stock_forums: $VXX Volume Click Here: http://t.co/QKRIa9YKFn Also See: $SVFC $ARIA $MYEC $GRCU ~
Stock Forums
22 Oct 14 04:03:44
$VXX Volume Click Here: http://t.co/QKRIa9YKFn Also See: $SVFC $ARIA $MYEC $GRCU ~
Chasing Stars
22 Oct 14 01:47:04
$UGAZ E.P.S. Click Here: http://t.co/2JIbueBR0h Also See: $UNG $CMRX $HZU.TO $ARIA ~
Investors Hangout
22 Oct 14 00:50:35
$TRV Chart Click Here: http://t.co/93sR6ruFKB Also See: $X $XLB $ARIA $UBT ~
Investors Hangout
22 Oct 14 00:29:23
$TMV Ideas Click Here: http://t.co/naaOT8BGwU Also See: $ARIA $PGAL $AA $GLOG ~
Rosner Stocks
21 Oct 14 22:39:06
$SMH P/E Ratio Click Here: http://t.co/amw597yCu4 Also See: $ARIA $UBT $PSCF $BITA ~
Victor Roberts, MD
21 Oct 14 22:19:35
Commented on StockTwits: Free market rules! Let bidding wars start for $ARIA pipeline drugs, not for whole Co! i'... http://t.co/KSl2kGRxvK
21 Oct 14 22:06:29
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/z2noBUWrEP $FASC $ARIA $TUCN
Rosner Stocks
21 Oct 14 22:04:40
$SLB Stock Forum Click Here: http://t.co/l40EhmXvUu Also See: $WFC $ARIA $MBLY $ARWR ~
By  +Follow October 9, 2013 8:03AM



blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.